Table 1. Estimation of XCI Ratio of in silico phased SNPs by beta testing.
Expected XCI ratio | Pseudo-maternal | SD | Pseudo-paternal | SD | Observed XCI Ratio |
(%) | mean ratio (%) | mean ratio (%) | (%) | ||
100∶0 | 99.64 | 1.81 | 0.06 | 0.31 | 99.64: 0.06 |
95∶5 | 95.46 | 11.88 | 3.91 | 10.83 | 95.46: 3.91 |
90∶10 | 90.63 | 15.12 | 7.96 | 14.63 | 90.63: 7.96 |
85∶15 | 84.82 | 14.35 | 13.11 | 14.79 | 84.82: 13.11 |
80∶20 | 78.91 | 12.91 | 18.01 | 15.40 | 78.91: 18.01 |
75∶25 | 74.31 | 12.63 | 22.59 | 11.61 | 74.31: 22.59 |
70∶30 | 69.76 | 14.02 | 28.87 | 10.94 | 69.76: 28.87 |
65∶35 | 63.25 | 11.59 | 34.11 | 10.78 | 63.25: 34.11 |
60∶40 | 58.76 | 11.47 | 39.15 | 11.58 | 58.76: 39.15 |
55∶45 | 54.05 | 11.51 | 42.88 | 14.08 | 54.05: 42.88 |
50∶50 | 49.25 | 11.79 | 47.84 | 12.00 | 49.25: 47.84 |
XCI = X inactivation, SD = standard deviation.